Immunologist Zachary Rubin explains how the World Health Organization decides which strains of influenza end up in annual flu ...
The University of Liverpool rand CyanoCapture Ltd are joining forces to develop the next generation of carboxysome-based ...
CollPlant Biotechnologies , a regenerative and aesthetic medicine company developing innovative technologies and products ...
The collaboration between the University and CyanoCapture will focus on developing innovative methods for producing targeted delivery systems using engineered carboxysomes, combining advanced ...
A head-to-head study by Israel's Technion found that CollPlant's rhCollagen-based bioink, Collink.3D™, outperformed Matrigel®, a leading extracellular ...
TipRanks on MSN
CollPlant Expands rhCollagen Distribution in North America
Collplant Holdings ( ($CLGN) ) has issued an announcement. On October 27, 2025, CollPlant Biotechnologies announced the expansion of its ...
An update from Collplant Holdings ( ($CLGN) ) is now available. On October 16, 2025, CollPlant Biotechnologies announced the development of a ...
GEAC and RCGM remain robust, science-driven regulatory bodies committed to biosafety and public interest; constructive ...
NLS Pharmaceutics Ltd. ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system and neurodegenerative disorders and Kadimastem Ltd. ("Kadimastem"), a clinical-stage ...
Research and Development Expenses -- $9.6 million in the third quarter of 2025, down from $12.3 million in Q3 2024, due to ...
This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping ...
DNA, often called the blueprint of life, is built from four chemical building blocks known as deoxy-nucleoside triphosphates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback